Clinical trial
Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine…
NCT02044094 · Indivior Inc., Industry · Completed
Key facts
| NCT number | NCT02044094 |
|---|---|
| Title | Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder |
| Official title | A Multiple-Dose Study of Blockade of Subjective Opioid Effects, Plasma Levels, and Safety of Subcutaneous Injections of Depot Buprenorphine (RBP-6000) in Subjects With Opioid Use Disorder |
| Lead sponsor | Indivior Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Opioid Use Disorder |
| Intervention type | Drug |
| Interventions | Buprenorphine, buprenorphine and naloxone, hydromorphone, placebo |
| Enrollment | 39 |
| Start date | Nov 1, 2013 |
| Primary completion | Jul 1, 2014 |
| Completion | Jul 1, 2014 |
| First posted | Jan 23, 2014 |
| Last update posted | Apr 24, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: